take the invention and commercialize it. Sometimes, but not always. At other times a non-exclusive license, particularly on a basic enabling technology, will ultimately maximize the invention's impact on society by allowing a large number of people to commercialize in different areas, to try out different things and see if they work, and the like. University policies might be made more nuanced than simply a choice between exclusive and non-exclusive licenses. For example, they might grant fieldspecific exclusivity, or exclusivity only for a limited term, or exclusivity only for commercial sales while exempting research, and they might condition continued exclusivity on achievement of certain dissemination goals. Particularly in the software context, there are many circumstances in which the social impact of technology transfer is maximized either by the university not patenting at all or by granting licenses to those patents on a royalty-free basis to all comers.
Finally, I think we can learn something about the raging debate over who is a patent troll and what to do about trolls by looking at university patents. Universities are non-practicing entities. They share some characteristics with trolls, at least if the term is broadly defined, but they are not trolls. Asking what distinguishes universities from trolls can actually help us figure out what concerns us about trolls. What we ought to do is abandon the search for a group of individual companies to define as bad actors. In my view, troll is as troll does. Universities will sometimes be bad actors. So will non-manufacturing patent owners. So will manufacturing patent owners. Instead of singling out bad actors, we should focus on the bad acts and the laws that make them possible.
I. COMPLAINTS ABOUT UNIVERSITY PATENTS
The confluence of two significant developments in modern patent practice leads me to write a paper with such a provocative title. 
A. The Rise of Patent Hold-up
The first development is the rise of hold-up as a primary component of patent litigation and patent licensing. You can call this the troll problem if you like.
2 I prefer to think of it as the holdup problem. But whatever we call the problem, it seems quite clear that more and more patent litigation is being filed, and significant money is being made, by non-manufacturing entitiesentities that don't themselves actually make the product and in many cases don't actually engage in developing the technology very far at all. Many of these entities also engage in tactics that allow them to lay low and then take a mature industry by surprise once participants in the industry have made irreversible investments.
3
The hold-up or troll problem is particularly significant in component-driven industries, notably information technology ("IT"), where the problem is compounded by the fact that a product developer such as Intel that must aggregate thousands of different inventions into its semiconductor chip is vulnerable to hold-up by any one of the thousands of inventors. Patent owners in those component industries can capture far more than the intrinsic value of their invention, because under longstanding patent law 4 patent owners have had the right not just to sue and get paid the percentage of the value contributed by their invention but to enjoin the sale of Intel's entire chip until it can design a new chip that avoids infringing that patent, something that might take years and require investing billions of dollars in a new fab. 5 These factors have combined to produce the growth industry of the new millennium: patent hold-up. Hundreds of companies 2 The term "patent troll" was coined in the late 1990s by Peter Detkin, then assistant general counsel at Intel, to refer to patent owners who hide under bridges they did not build to pop out and demand money from surprised passers-by. I'll talk about some definitions of "patent troll" at the end of this Article. On this problem and how it leads to settlements well in excess of the intrinsic value of the patent, see Mark A. Lemley are engaging in efforts to capture not just the value of what they contributed to an invention, but also a disproportionate share of somebody else's product.
B. The Rise of University Patenting
The second development in the last three decades is the massive surge in university patenting. 6 Universities obtained sixteen times as many patents in 2004 as in 1980, 7 and universities had 100 times as many technology transfer offices. 8 In significant measure this is a result of the Bayh-Dole Act, 9 which not only permits but encourages university patenting of federally-funded inventions. But it is also a reflection of the growth in importance of patents more generally. Those university patents don't sit dormant; universities license them to companies for over $1 billion a year in revenue. 10 Patents are now a significant contributor to some university bottom lines. And importantly, more and more university patents are patents on the very earliest stages of technology. It is universities, perhaps not surprisingly given their role in basic research, who are patenting the basic building blocks in new technologies. We see this with particular force in 6 For a discussion of the growth of university patenting and its potential risks, see DAVID C. MOWERY ET 
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ARE UNIVERSITIES PATENT TROLLS? 615 nanotechnology, an area I have studied in detail. 11 Universities, which account for 1% of patents on average across all fields, account for 12% of all patents in nanotechnology, and more than two-thirds of what I identify as the basic building block patents in nanotechnology. 12 The other area in which university patents are significant is biotechnology, where they represent about 18% of all patents.
13 As a result, universities have met a much bigger role in patenting than they ever have before.
C. Are Universities Engaged in Hold-up?
At the confluence of these developments is a growing frustration on the part of industry with the role of universities as patent owners. Time and again, when I talk to people in a variety of industries, their view is that universities are the new patent trolls. One even referred publicly to universities as "crack addicts" driven by "small-minded tech transfer offices" addicted to patent royalties.
14 Why such a vehement reaction? One important reason is that universities are non-manufacturing entities. They don't sell products. I don't think that necessarily means they're bad actors. But it does mean that their incentives in dealing with the patent system align in many ways with those of private-sector patent licensing shops. One of the assumptions corporations in patentintensive industries (such as IT or increasingly biotechnology) make about patenting is symmetry: that if a competitor sues you for infringement you can sue them back. That symmetry deters much patent litigation in the industries in which it operates. 15 that symmetry doesn't often exist for non-manufacturing entities. Universities aren't going to trade their patents away in exchange for a cross-license, because they don't need a license to other people's patent rights. 16 Instead, they want money. And to an IT general counsel who deals with dozens of threats of suit every year, any patent owner in that position looks an awful lot like a patent troll. In short, there's definitely a sense among industry representatives that universities are greedy when it comes to licensing patents. 17 Compounding the perception of greed is that university patent licensing offices have strong institutional incentives to grant exclusive rather than non-exclusive licenses, for various reasons. First, exclusive licensing royalty rates are almost always higher than non-exclusive rates. That's not surprising, since the licensee is getting more from an exclusive license than from a nonexclusive license. From the perspective of a technology transfer office focused on this quarter's bottom line, that higher royalty rate is hard to turn down. Second, the companies with which they are negotiating often want exclusivity. 18 They are especially likely to get it if the company in question is a faculty-organized startup. 
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ARE UNIVERSITIES PATENT TROLLS? 617 impacts the technology transfer office's bottom line. The result is that the overwhelming majority of university patent licenses are exclusive. The Association of University Technology Managers ("AUTM") reports that more than 60% of its members' 2005 licenses were exclusive. 20 In the nanotech licenses I studied (just a few dozen, admittedly), between 95 and 100% of the university licenses granted were exclusive.
21
One example from the biotechnology field of an exclusive license to an enabling technology is the Wisconsin Alumni Research Foundation's ("WARF") field-exclusive license to Geron of all stem cell patents, granted shortly before those stem cell patents became extraordinarily valuable because the Bush administration obstructed the development of new stem cell lines.
22
In fact, however, this higher royalty rate may or may not translate into a higher revenue stream for the university. Whether it does, depends on the nature of the technology being licensed. For certain basic building blocks-what I call "enabling technologies"-opening up licensing to many innovators who can develop different uses will generate substantial improvements, while giving an exclusive license to only one person will generate fewer improvements. [Vol. 18 development of a technology if the licensee doesn't deliver.
24
Even if in the long run non-exclusive licensing of many technologies actually increases university revenue, in the short run a university tech-transfer office seeking to maximize the amount of money that the office generates will tend to grant exclusive licenses. Exclusive licenses aren't necessarily bad-a point I discuss below-but they raise concerns about the effective diffusion of new technologies.
A final reason for industry concern about university patenting is that universities are increasingly enforcing their patents. Recent years have seen high-profile cases litigated to judgment by the University of California, the University of Rochester, Harvard, MIT, Columbia, Stanford, and suits filed by many other universities. One notable example is Eolas Technologies, Inc. v. Microsoft Corp., 25 in which the University of California licensed a software patent to a company that really does look like a patent troll, however you want to define that term, and then shared with that company a jury award of $520.6 million against Microsoft. 26 Universities, recognizing patent licensing and litigation as an important revenue source in the modern environment, have been active in politics, largely in alignment with the life sciences industries (from which most university patent revenue comes), in opposing most of the effective pieces of draft patent reform legislation. Universities and continuation applications. The patent reform bill 27 also faced attacks from some universities seeking to eliminate the move to first inventor to file, which doesn't benefit them because they tend to file later than commercial entities, and eliminate the creation of prior user rights, which also don't benefit them since they aren't generally using the inventions. These university preferences should not be surprising, at least if we view the university as a profit-maximizing entity rather than one concerned with the social good. Like other non-manufacturing entities, after all, universities are first and foremost intellectual property ("IP") owners, not IP licensees.
The result is a felt sense among a lot of people that universities are not good actors in the patent system. Given the difficulty anyone has had in defining a patent troll, it is easy to move from that conclusion to the idea that universities are trolls too. I think it is worth questioning that leap. There is something going on here, but I'm not sure that it is reasonable to equate university patents with private troll behavior. The common refrain in complaints about patent trolls is that they are not contributing anything to society, but rather obtaining and asserting patents covering technology independently developed by defendants. The question remaining to be answered is whether the same is true of university patents. In other words, it's worth asking whether society needs or wants university patents at all.
II. DO WE NEED UNIVERSITY PATENTS?
From the perspective of the university, one justification for university patents may be to fund universities. More money is better than less money, and the billion dollars each year in licensing is a substantial new revenue source for universities, most of which goes to research, and some of which goes to education. If you think research and education are under-funded in our society today, as I tend to believe, generating that additional revenue [Vol. 18 sounds useful in a way that paying for-profit licensing shops doesn't. But the additional revenue is not costless: it is money that comes out of industry pockets, and at least some of it would otherwise have gone to industry research and development, or to selling better products, or to providing products more cheaply. So, it is worth thinking about the costs of patents as a pure wealthtransfer mechanism. Most economists would agree that if our goal is to adequately fund higher education, patent litigation is an inefficient way of doing so. 28 Further, some argue that a culture of patenting imposes costs on the university or on academic research more generally. 29 University scientists focused on patenting may delay or even forego publication in favor of IP protection. 30 And there is substantial literature on how the shift to university patenting has actually moved universities away from basic research and towards more applied research in ways that are arguably bad for society in the long run.
31
The risk is not so much that individual professors will change their research habits as that the departments that grow will be ones that generate money, and that the new faculty hiring slots will go to those who engage in revenue-generating applied research. 
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can also direct research to particular ends, so in practice they aren't perfect funding mechanisms either.
Why else might society need university patents? The classic justification for patents-creating incentives to innovatearguably isn't nearly as important in the university context as in the private sector. I think it unlikely that university scientists would not do research or invent in the absence of patent protection. There are plenty of other incentives for university scientists to engage in research, including curiosity, academic prestige, and tenure and promotion. Further, university inventors are generally funded by grants or departmental revenue, must assign their rights to the university, 32 and don't necessarily see any tangible benefit from university patenting of their inventions. Now, this doesn't necessarily mean that patents have no additional effect. It may be that patents generate some revenue which is refunded to the researcher's department and supports further research, and even that the prospect of that additional funding motivates some research. But the contribution of patents to university incentives to innovate seems smaller than in profit-driven companies.
The final reason we might want university patents-and the argument that actually prevailed in the congressional debates over Bayh-Dole-is the commercialization argument. Unlike the classic incentive story, commercialization theory argues that it is not so much the act of invention, but instead the act of turning that invention into a marketable product that requires investment and therefore the exclusion of competition. 33 According to this theory, university inventions will languish and not be commercialized unless we give someone (initially the university, but presumably eventually a private company to which the right is licensed or transferred) control over the invention, and therefore incentive to invest in developing and marketing it. This argument seems particularly strong with respect to university inventions, since we can reasonably expect those inventions involve more basic research, and therefore to be made at an earlier stage, than private inventions.
There is some debate as to whether the commercialization theory is actually true of university inventions. Mowery, Nelson, Sampat, and Ziedonis suggest that Bayh-Dole was based on concerns that were misstated, or at least overstated. 34 They argue that there was a good deal of technology transfer without university patents in the decades before Bayh-Dole, and that even today there is plenty of university technology transfer that occurs in the absence of patents.
35 By contrast, the prevailing wisdom seems to be that university patents increase commercialization, and therefore that Bayh-Dole has been a success. 36 Certainly they increase commercialization deals between universities and companies, 37 though it is hard to know the extent to which that simply reflects the fact that once a patent issues, the company in question needs a license in order to commercialize the technology. 
My own view is that the validity of commercialization theory depends a great deal on the industry in question and
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nature of the technology. In the pharmaceutical and biotechnology industries, where coming up with an invention is only the first step down a very long road of regulatory process that can take hundreds of millions of dollars and several years, the commercialization argument makes some sense. The university generally isn't going to seek regulatory approval, and arguably we need to give somebody exclusive rights to induce them to make the regulatory investments that the university itself isn't going to make. We give the right to the university, but we do so expecting that they will transfer or exclusively license that right to a private company that will recoup the hundreds of millions of dollars they spend in clinical trials, product development, and marketing.
38
Other industries might also have a long post-invention development cycle and therefore be good candidates for commercialization theory. That might be true of basic building block technologies like nanotechnology, where we expect a very long road between the development of the invention and the ultimate commercialization, 39 though it is likely too early to say for sure how nanotech will develop. In these industries, Bayh-Dole is probably a good thing.
On the other hand, I'm doubtful that central control is necessary to produce commercialization in the majority of other industries. 40 Bear in mind that the commercialization story is at base anti-market: it assumes, contrary to centuries of economic 38 Interestingly, though, even industry players in the pharmaceutical industry sometimes lament university reliance on exclusive licensing. See Siepmann, supra note 35, at 236-37 (quoting Joshua Kalkstein, corporate counsel for Pfizer). 39 Lemley, Nanotechnology, supra note 11, at 628-29. 40 Empirical evidence supports the conclusion that patenting reduces rather than increases technology diffusion overall. Murray and Stern find that patenting is associated with reduced citation to an academic publication associated with the patent. learning, that ordinary profit motives will not produce efficient allocation of resources and that we need to vest exclusive control of a technology or market in one actor in order to get that efficient allocation. 41 Even if we think that's true in the pharmaceutical or biotechnology industries because of the regulatory barriers to entry in those markets, we should not conclude exclusivity is always or even generally required to encourage a company to bring a product to market. 42 In the IT industries, and even in industries like medical devices, there is no reason to believe that exclusive rights are necessary to encourage commercialization of the technology. It is true even in those industries that when an inventor has gotten to the point where she can patent something, there may still be development and marketing work to be done. But we get plenty of both in a competitive marketplace because the companies who engage in product development and marketing can reap enough of the benefits of that investment to make it worthwhile. And indeed we have seen an enormous number of technologies commercialized out of universities throughout the 20th Century without need of university patents. Think of the computer, the world wide web, search engines, relational databases, and any number of software programs. 43 The need for university patents, in short, depends critically on the technology at issue. I think much of the industry frustration with the role of university patents stems from the failure of some university technology transfer offices to recognize and adapt to these technology differences. As noted above, technology transfer offices have strong incentives to maximize revenue from patent licensing. To achieve this, they have adopted the life sciences More and more property rights scholars seem to forget the benefits of a market economy. I have heard academics suggest, for instance, that we may not get efficient entry of Indian restaurants into particular neighborhoods unless we grant some sort of regional exclusivity. Maybe that's right, but I doubt it. The market has worked pretty well in the past, and we should be reluctant to forego its benefits unless we're quite sure that the alternative will be better. 
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ARE UNIVERSITIES PATENT TROLLS? 625 model, where exclusive rights and patents seem to make sense because of the regulatory delays, as their general approach to patent licensing. But they are increasingly using it in software and other information technologies. 44 The result is frustration on the part of industry counterparts in industries like computers or telecommunications that are more interested in freedom to operate than in exclusive rights over a new technology. It may also be frustration on the part of tech transfer offices; less than 1% of all university patent licenses generate over $1 million in revenue. 45 And efforts to commercialize the rest is what leads to a lot of the more worrisome patent licenses in cases like Eolas.
III. LESSONS FROM THE UNIVERSITY PATENT EXPERIENCE
A. Towards an Enlightened University Patent Policy
Universities should take a broader view of their role in technology transfer. University technology transfer ought to have as its goal maximizing the social impact of technology, not merely maximizing the university's licensing revenue. 47 A university is more than just a private for-profit entity. It is a public-regarding institution that should be advancing the development and spread of knowledge and the beneficial use of that knowledge. 48 Sometimes those goals will coincide with the university's short-term financial interests. Sometimes universities will maximize the impact of an invention on society by granting exclusive licenses for substantial revenue to a company that will take the invention and 44 See Allison et al., supra note 6, § 1 (documenting the growth in university software patenting). Osenga, by contrast, suggests that universities should act more like private businesses in licensing their patents, paying more attention to the short-run bottom line. Osenga, supra note 17, at 2. Again, I disagree. [Vol. 18 commercialize it. Sometimes, but not always. At other times a non-exclusive license, particularly on a basic enabling technology, will ultimately maximize the invention's impact on society by allowing a large number of people to commercialize in different areas, to try out different things and see if they work, and the like. 49 Universities can still earn revenue from nonexclusive licenses, and for enabling technologies they might even maximize their revenue in the long term by granting nonexclusive rather than exclusive licenses.
50
University policies might be made more nuanced than simply a choice between exclusive and nonexclusive licenses. For example, they might grant field-specific exclusivity, or exclusivity only for a limited term, or exclusivity only for commercial sales while exempting research, 51 and they might condition continued exclusivity on achievement of certain dissemination goals. 
The key university patents on enabling technologies in biotechnology, issued to Cohen and Boyer for the creation of chimeric organisms and to Axel for methods of inserting genes into a cell, were licensed nonexclusively because of then-existing NIH requirements. See Wysocki, supra note 7, at A1. They made enormous sums of money for Stanford, the University of California, and Columbia, arguably because, not in spite of, the nonexclusivity of the licenses. If we are to achieve the goal of maximizing the social benefit of a university invention to society, universities must first recognize their proper role in society and how that role affects patent policies. An important first step in that education process is to end the isolation of university technology transfer or licensing offices from the rest of the university. 55 If universities treat licensing offices as revenue generation devices, evaluated on how much money they bring in each quarter, the result will be university patent policies that are not always or even often consonant with the ultimate public interest. 56 The For a discussion of the various ways in which university technology transfer offices are organized today, see Ritchie de Larena, supra note 8, at 1413. 56 See id. at 1416-17 ("One point that most technology-transfer managers agree upon is that it is not wise to judge a university's technology-transfer office solely on licensing income.").
57
For example, the University of Colorado has outsourced much of its patent licensing to Competitive Technologies Inc. more enlightened policies. A number of universities have taken significant steps in this regard, 58 but more remains to be done.
B. Legal Constraints on Unenlightened Universities
If universities don't develop such policies voluntarily, society may have other mechanisms to ensure that university patents don't impede innovation. Federal funding agencies can play a role. The National Institutes of Health ("NIH") has, at various times in the past, imposed mandates requiring universities to grant certain types of licenses to their work.
59
The Bayh-Dole Act permits the government to exercise "march-in rights," requiring that particular patents be licensed on non-exclusive terms, 60 though those rights have not been used, and may prove difficult to use. 61 Some have even suggested that publicly funded research should be subject to compulsory license. 62 Alternatively, as universities become more and more vulnerable to patent infringement suits themselves, 63 private sector patent owners may be able to create some of the symmetry that drives cross-licenses in industries like semiconductors by obtaining patents that universities infringe and threatening to assert them against any university who sues them for patent infringement. 64 These measures might turn out to be necessary, but I'd like to see us try first to solve the problem not by imposing a solution, but by encouraging universities to take the first step in recognizing their social responsibility associated with their patents. rights. 70 University patent owners aren't trolls in my view when they contribute previously unknown technology to society, rather than just imposing costs on others by obtaining and asserting legal rights over inventions independently developed by others.
71
In the abstract, I think we could successfully define patent trolls by distinguishing cases in which non-manufacturing entities license only the right not to be sued from cases in which the patent owner actually engages in technology transfer. But that's only in the abstract. Were a court ever to announce such a definition, it would immediately be gamed. All true trolls would start passing on some mandatory know-how along with their patent licenses in order to avoid being categorized as trolls.
What we ought to do instead is abandon the search for a group of individual companies to define as trolls. We don't need to focus on identifying bad actors. In my view, troll is as troll does. Universities will sometimes be bad actors. Nonmanufacturing patent owners will sometimes be bad actors. Manufacturing patent owners will sometimes be bad actors. Instead of singling out bad actors, we should focus on the bad acts and the laws that make them possible. We will solve the troll problem not by hunting down and eliminating trolls, but by hunting down and eliminating the many legal rules that facilitate the capture by patent owners of a disproportionate share of an irreversible investment. And that process is well underway. We should encourage reform of current continuation practice, which allows patent owners to hide the true nature of their invention until late in the process and facilitates their later claiming to have invented something they did not. 72 We 70 See generally ASHISH ARORA ET AL., MARKETS FOR TECHNOLOGY (2001) (noting the contributions of technology markets). should focus on reform of the willfulness doctrine, under which a patent owner can get treble damages from an independent inventor merely by telling them about the patent and which has the perverse effect of causing people to try to avoid learning of patents. 73 We should focus on reform of royalty calculation rules that give a disproportionate award of damages to patent owners in component industries because they don't adequately take account of the contributions of other aspects of the invention. 74 And we should take the opportunity presented by the Supreme Court's eBay decision 75 to craft intelligent standards for deciding when to grant injunctive relief. If we change the rules that make patent hold-up such an attractive revenue generator, we won't have to worry about the question of whether or not universities-or anyone else-are patent trolls. We will have eliminated the problem of opportunistic behavior that interferes with innovation, something we want to stop regardless of what we call it.
